Results 261 to 270 of about 238,876 (343)

Evaluating Sex Disparity in Pancreatic Ductal Adenocarcinoma Risk in the UK Biobank Cohort

United European Gastroenterology Journal, EarlyView.
ABSTRACT Background The incidence of pancreatic ductal adenocarcinoma (PDAC) is lower in females than males (19.0 vs. 20.2 for 100,000 individuals in Europe). This disparity is commonly attributed to differences in exposure to lifestyle risk factors such as smoking and alcohol consumption; however, hormonal activity may also play a role. Objective This
Giulia Peduzzi, Roberto Pellungrini, Livia Archibugi, Federico Canzian, Cosmeri Rizzato, Gabriele Capurso, Daniele Campa   +6 more
wiley   +1 more source

Effect of Androgens on Human Fascia. [PDF]

Biology (Basel)
Fede C, Sun Y, Zhao X, Angelini A, Ruggieri P, Stecco C.   +5 more
europepmc   +1 more source

STUDY ON ANDROGEN METABOLISM IN UROLOGICAL FIELDS

, 1968
Hiroshi Ohmuro
openalex   +2 more sources

Unveiling the potential of emerging microRNA panels as diagnostic biomarkers for prostate cancer: A review

UroPrecision, EarlyView.
Abstract Prostate cancer (PCa) is a multifaceted disease that envelops 1.41 million new cases globally. It is the second most common cancer reported in men. Its heterogeneity and indolent growth, coupled with incompetent early screening methods such as serum prostate‐specific antigen level estimations and digital rectal examinations, contribute to its ...
Anveshika Manoj, Gautam Prasad, Mohammad Kaleem Ahmad   +2 more
wiley   +1 more source

Studies on the Secretion and Metabolism of Androgens Using Double Radioactive Tracer Technique

, 1966
Tadashi Miyake, M Fukase, Tsuyoshi Kono, Teruya Yoshimi   +3 more
openalex   +2 more sources

Development of a prognostic nomogram and genetic insights for prostate cancer patients with secondary primary malignancies: A SEER retrospective cohort study and Mendelian randomization analysis

UroPrecision, EarlyView.
Abstract Background Prostate cancer (PCa) patients are at risk of developing second primary malignancies (SPMs), which can significantly shorten their survival. Understanding the risk of SPMs and associated factors is crucial to the optimization of patient follow‐up.
Qi Zhang, Lufan Liang, Ziyu Liu, Ziyang Yang, Jiahao Cheng, Xuan Li, Yueting Huang, Weisi Chen, Jiazhen Yin, Ligong Chen, Zhang Cao, Di Gu   +11 more
wiley   +1 more source

Society for Endocrinology Clinical Practice Guideline for the Evaluation of Androgen Excess in Women. [PDF]

Clin Endocrinol (Oxf)
Elhassan YS, Hawley JM, Cussen L, Abbara A, Clarke SA, Kempegowda P, Dhillon-Smith RK, Thadani P, Busby M, Owusu-Darkwah L, Marrington R, Duncan WC, Semple RK, Quinton R, O'Reilly MW.   +14 more
europepmc   +1 more source

CONTROLLED EVALUATION OF HEMODIALYSIS PATIENTS ON NANDROLONE DECANOATE (ND) VS TESTOSTERONE ENANTHATE (TE) (ANDROGENS AND DIALYSIS PATIENT)

, 1979
Mahdi Mirahmadi, N.D. Vaziri, Joanne Gorman   +2 more
openalex   +1 more source

Organoid‐based novel technology for antitumor drug screening

VIEW, EarlyView.
Organoids represent a cutting‐edge research model that closely mimics in vivo organ physiology, making them highly valuable for tumor immunotherapy drug screening. This review explores the integration of organoids with advanced technologies, such as gene editing, 3D bioprinting, and AI, highlighting novel fusion platforms and their applications.
Yu Su, Yuan Chen, Guanning Wei, Yihai Shi   +3 more
wiley   +1 more source

Association of obesity and adrenal androgen levels with bone age progression in boys with premature adrenarche. [PDF]

Ann Pediatr Endocrinol Metab
Lee K, Choi J, Choe Y, Yang S.
europepmc   +1 more source